Code Snippets
curl "https://financialdata.net/api/v1/institutional-holdings?identifier=GILD&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/institutional-holdings?identifier=GILD&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/institutional-holdings?identifier=GILD&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"investor_name": "Whitener Capital Management, Inc.",
"central_index_key": "0000825217",
"period_of_report": "2026-09-30",
"issuer_name": "GILEAD SCIENCES INC",
"trading_symbol": "GILD",
"cusip_number": "375558103",
"title_of_security": "COM",
"market_value": 1218417.0,
"amount_of_securities": 8174,
"price_per_security": 149.060068509909,
"shares_or_principal": "SH",
"put_or_call": "N/A",
"investment_discretion": "SOLE",
"portfolio_weight": 0.00243159292030365
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol or CUSIP number of a security, or the institutional investor's central index key. The latter is assigned to the investor by the US Securities and Exchange Commission. (e.g., MSFT, 594918104, 0001067983) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 100) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Institutional holdings are the securities in an investment portfolio owned by investment or pension funds, insurance companies, investment firms, or other large organizations that manage funds on behalf of others. The API endpoint provides data on institutional investors with holdings of at least $100 million. There is a limit of 100 records per API call.
Company Profile
GILEAD SCIENCES, INC.
NASDAQ: GILD- Market Cap:$103.20B
- ISIN:US3755581036
- Fiscal Year End:12/31
- CEO:Daniel O'Day
- Employees:17000
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
GILD Datasets
GILD Stock QuotesGILD Stock PricesGILD Minute PricesGILD Company InformationGILD Key MetricsGILD Market CapGILD Employee CountGILD Executive CompensationGILD Income StatementsGILD Balance Sheet StatementsGILD Cash Flow StatementsGILD Insider TransactionsGILD Senate TradingGILD Analyst ConsensusGILD Earnings ReleasesGILD Stock SplitsGILD DividendsGILD Short Interest